US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

WisdomTree International High Dividend Fund

43.33

-0.0900-0.21%

Volume:3.29K

Turnover:142.44K

Market Cap:379.14M

PE:- -

High:43.40

Open:43.32

Low:43.31

Close:43.42

Loading ...

Overview Company News Filings

Mileto Tecnologia Partners with SES for DTH Platform Delivery in Brazil

Telesat Reports Results for the Quarter and Twelve Months Ended December 31, 2024

Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?

Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?

High Growth Tech Stocks In India For October 2024

Simply Wall St.

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial

Terms Of Takeover Bid By Tinexta Defence For DTH Set For Oct 14 To Nov 7

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTH\",,,,,undefined,":{"symbol":"DTH","market":"US","secType":"STK","nameCN":"WisdomTree International High Dividend Fund","latestPrice":43.33,"timestamp":1745591274500,"preClose":43.42,"halted":0,"volume":3287,"delay":0,"floatShares":8750000,"shares":8750000,"eps":0,"marketStatus":"Trading","change":-0.09,"latestTime":"04-25 10:29:11 EDT","open":43.32,"high":43.4,"low":43.31,"amount":142443.735908,"amplitude":0.002073,"askPrice":43.89,"askSize":100,"bidPrice":42.75,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745611200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":43.42,"sharesOutstanding":8750000,"nav":43.004,"aum":376285000,"bidAskSpread":0.001366,"postHourTrading":{"tag":"盘后","latestPrice":43.42,"preClose":43.42,"latestTime":"18:40 EDT","volume":19,"amount":825.33,"timestamp":1745534446674},"volumeRatio":0.70241,"impliedVol":0.1907,"impliedVolPercentile":0.048},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTH\",,,,,undefined,":{"symbol":"DTH","floatShares":8750000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.70241,"shares":8750000,"dividePrice":1.9871,"high":43.4,"amplitude":0.002073,"preClose":43.42,"low":43.31,"week52Low":37.11,"pbRate":"--","week52High":43.4436,"institutionHeld":0,"latestPrice":43.33,"eps":0,"divideRate":0.04586,"volume":3287,"delay":0,"ttmEps":0,"open":43.32,"prevYearClose":37.78,"prevWeekClose":42.21,"prevMonthClose":42.4609,"prevQuarterClose":42.4609,"fiveDayClose":42.21,"twentyDayClose":42.83,"sixtyDayClose":38.9525},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525061522","title":"Mileto Tecnologia Partners with SES for DTH Platform Delivery in Brazil","url":"https://stock-news.laohu8.com/highlight/detail?id=2525061522","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525061522?lang=en_us&edition=fundamental","pubTime":"2025-04-07 14:50","pubTimestamp":1744008600,"startTime":"0","endTime":"0","summary":"Brazil’s direct-to-home pay-TV service signs deal with SES to deliver high-quality content to more than 600,000 households. LUXEMBOURG, April 07, 2025----SES announced today a new content distribution agreement with Mileto Tecnologia for its direct-to-home  pay-TV platform. Under the agreement, SES will provide Mileto with capacity on the SES-6 satellite at the 40.5 degrees West TV neighborhood, providing coverage for delivery of its bouquet of HD channels to over 600,000 TV households across Brazil.The agreement follows Mileto’s recent acquisition of all the infrastructure and subscribers of Oi TV, one of Brazil’s largest and traditional satellite pay-TV services.\"A key part of the success of our Oi TV acquisition was the partnership with SES and knowing they would be able to seamlessly transition all existing subscribers without any impact to the customer experience,\" said Roberto Guenzburger, CEO at Mileto Tecnologia. \"The reliability and performance of SES’s service ensures we can ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mileto-tecnologia-partners-ses-dth-065000663.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DTH","SES","BK4096","BK4547","BK4603","BK4084","BK4585","BK4516","BK4588","GEO","SGBAF","BK4100","BK4165"],"gpt_icon":0},{"id":"2522372766","title":"Telesat Reports Results for the Quarter and Twelve Months Ended December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2522372766","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522372766?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":"OTTAWA, Ontario, March 27, 2025  -- Telesat , one of the world’s largest and most innovative satellite operators, today announced its financial results for the three and twelve-month periods ended December 31, 2024. All amounts are in Canadian dollars and reported under IFRS Accounting Standards unless otherwise noted.“Telesat achieved a great deal in 2024 and I’m pleased with our financial performance and, more importantly in terms of our future, the tremendous progress we made in moving Telesat Lightspeed, our advanced Low Earth Orbit  satellite program, forward,” commented Dan Goldberg, Telesat’s President and CEO. “Our financial results reflect our continued disciplined execution, delivering revenue and Adjusted EBITDA1 above our 2024 guidance as well as industry-leading Adjusted EBITDA margins1, a substantial GEO backlog2 of $1.1 billion, and significant cash flow.”","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telesat-reports-results-quarter-twelve-113000411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TSAT","DTH","BK4089","LEO"],"gpt_icon":0},{"id":"2514324903","title":"Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324903","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324903?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:20","pubTimestamp":1740741607,"startTime":"0","endTime":"0","summary":"The WisdomTree International High Dividend ETF  was launched on 06/16/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Developed World ETFs category of the market.The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.Market cap weighted indexes work great for investors who believe in market efficiency. They provide a low-cost, convenient and transparent way of replicating market returns.However, some investors believe in the possibility of beating the market through exceptional stock selection, and choose a different type of fund that tracks non-cap weighted strategies: smart beta.Non-cap weighted indexes try to choose stocks that have a better chance of risk-return performance, which is based on specific fundamental characteristics, or a mix of other such characteristics.So far this year, DTH has added about","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wisdomtree-international-high-dividend-etf-112007813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1804176565.USD","LU2236285917.USD","LU0672654240.SGD","FDN","LU0289961442.SGD","LU0320765646.SGD","BK4581","BK4588","BK4504","IEFA","LU2095319765.USD","LU0511384066.AUD","BK4112","LU0175139822.USD","LU2210149790.SGD","LU0320765059.SGD","BK4585","SHEL","LU0289960550.SGD","LU0109391861.USD","LU1162221912.USD","LU2265009873.SGD","LU0300736492.USD","LU2210150020.SGD","LU0708995401.HKD","LU0300736062.USD","LU0278409577.USD","LU0289739343.SGD","DTH","LU0098860793.USD","BK4550","BK4201","MSCI","LU1267930730.SGD","BK4534","EFA"],"gpt_icon":0},{"id":"2494802820","title":"Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2494802820","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494802820?lang=en_us&edition=fundamental","pubTime":"2024-12-25 19:20","pubTimestamp":1735125606,"startTime":"0","endTime":"0","summary":"The WisdomTree International High Dividend ETF  was launched on 06/16/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Broad Developed World ETFs category of the market.Products that are based on market cap weighted indexes, which are strategies designed to reflect a specific market segment or the market as a whole, have traditionally dominated the ETF industry.Market cap weighted indexes work great for investors who believe in market efficiency. They provide a low-cost, convenient and transparent way of replicating market returns.If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap weighted strategies.This kind of index follows this same mindset, as it attempts to pick stocks that have better chances of risk-return performance; non-cap weighted strategies base selection on certain fundamental characteristics, o","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/gUf3JPAiwp3PVjuDKftvaA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/gUf3JPAiwp3PVjuDKftvaA--~B/aD04NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wisdomtree-international-high-dividend-etf-112006574.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2129689605.HKD","LU0109391861.USD","BK4581","LU0511384066.AUD","TTE","EFA","BK4112","LU2237443465.HKD","LU2237443978.SGD","LU0672654240.SGD","LU0320765059.SGD","SHEL","LU2129689514.USD","BK4201","LU1804176565.USD","LU2237443382.USD","BK4534","BK4588","LU2237443622.USD","LU2236285917.USD","LU0278409577.USD","BK4550","LU2095319765.USD","LU0289960550.SGD","LU0289739343.SGD","BK4504","BK4585","DTH","LU0708995401.HKD","LU2237443895.HKD","BK4561","LU2237443549.SGD","LU2265009873.SGD","LU2129689431.USD","LU0300736492.USD","IEFA","LU0300736062.USD","LU1267930730.SGD","LU2210150020.SGD","LU0289961442.SGD","LU1162221912.USD","MSCI","LU0320765646.SGD","FDN","LU2210149790.SGD","LU0175139822.USD","LU0098860793.USD"],"gpt_icon":0},{"id":"2492546229","title":"Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761","url":"https://stock-news.laohu8.com/highlight/detail?id=2492546229","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492546229?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440400,"startTime":"0","endTime":"0","summary":"Favourable safety profile for world’s first LAG-3 agonist, IMP761, with no treatment related adverse events to dateAdditional safety data and assessment of PK/PD relationships to follow in first half ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/17/2998188/0/en/Immutep-Announces-Initial-Safety-Data-from-First-in-Human-Phase-I-Trial-Evaluating-IMP761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTH","IMMP","BK4139"],"gpt_icon":0},{"id":"2490212859","title":"BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®","url":"https://stock-news.laohu8.com/highlight/detail?id=2490212859","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490212859?lang=en_us&edition=fundamental","pubTime":"2024-12-11 20:50","pubTimestamp":1733921400,"startTime":"0","endTime":"0","summary":"Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated since 2022), double that of comparable patients in the lite","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995320/0/en/BriaCell-Presents-Unprecedented-Overall-Survival-Data-in-Metastatic-Breast-Cancer-in-Spotlight-Poster-at-2024-SABCS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4097","BK4086","CPI","MBC","CNS","OS","DTH","NLR"],"gpt_icon":0},{"id":"2486077540","title":"BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2486077540","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486077540?lang=en_us&edition=fundamental","pubTime":"2024-11-26 20:50","pubTimestamp":1732625400,"startTime":"0","endTime":"0","summary":"SABCS “Spotlight” poster to be presented on Wednesday, December 11, 2024 7:00 AM – 8:30 AM CST highlights positive BriaCell survival and clinical benefit data across all metastatic breast cancer patient subtypes. Median overall survival of 13.4 months exceeds historical controls. Phase 2 final median overall survival calculation is pending, as many patients remain alive. Five poster presentations to feature increased presence of cancer fighting CD8+ “killer” T cell in metastatic breast cancer tumors, response in central nervous system  metastases and additional Bria-IMT clinical data from the Phase 2 trial of Bria-IMT + immune check point inhibitor in metastatic breast cancer. Collaboration with the Medical College of Wisconsin will investigate use of Bria-IMT + CPI in any cancer patient with central nervous system  metastases","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Fapu7tR5DxauNKta6Slkew--~B/aD0zODY7dz00NDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/17b9221138faf4e9b9308828981b6076"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-2024-sabcs-spotlight-poster-125000786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CPI","OS","MBC","BK4086","BCTXW","DTH","BK4135","BK4097","BCTX","BK4139","CNS"],"gpt_icon":0},{"id":"2479328407","title":"Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2479328407","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479328407?lang=en_us&edition=fundamental","pubTime":"2024-10-29 21:00","pubTimestamp":1730206800,"startTime":"0","endTime":"0","summary":"- Data from multiple Phase 1b studies in inflammatory skin conditions demonstrate durable dose-dependent improvements in physician-assessed disease activity and patient-reported outcomes -. - Biomarker analyses demonstrate plurality of Treg-mediated pathways with potential effect on tissue resident memory T cell populations resulting in sustained efficacy seen in the antigen challenged mouse model and in clinical trials -. SAN FRANCISCO, Oct. 29, 2024 /PRNewswire/ -- Nektar Therapeutics , today announced the publication of peer-reviewed data from two Phase 1b studies in Nature Communications highlighting the efficacy, safety, and tolerability of rezpegaldesleukin in patients with atopic dermatitis  and psoriasis .Rezpegaldesleukin is a first-in-class interleukin-2 receptor  agonist that enhances the activity of regulatory T cells  with promising dose-dependent clinical activity across multiple physician-assessed and patient-reported endpoints for AD and PsO.Rezpegaldesleukin was evalua","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/rtboK12ORMgNOQ6pHWHlMg--~B/aD04Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/ed402d287488a53ce89b92f9b5ed2bb0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/rtboK12ORMgNOQ6pHWHlMg--~B/aD04Mzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/ed402d287488a53ce89b92f9b5ed2bb0"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/nektar-announces-publication-nature-communications-130000590.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nektar-announces-publication-nature-communications-130000590.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DTH","BK4007","NKTR"],"gpt_icon":0},{"id":"2477680304","title":"Is WisdomTree International High Dividend ETF (DTH) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2477680304","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477680304?lang=en_us&edition=fundamental","pubTime":"2024-10-24 18:20","pubTimestamp":1729765205,"startTime":"0","endTime":"0","summary":"Launched on 06/16/2006, the WisdomTree International High Dividend ETF  is a smart beta exchange traded fund offering broad exposure to the Broad Developed World ETFs category of the market.Market cap weighted indexes were created to reflect the market, or a specific segment of the market, and the ETF industry has traditionally been dominated by products based on this strategy.Investors who believe in market efficiency should consider market cap indexes, as they replicate market returns in a low-cost, convenient, and transparent way.If you're the kind of investor who would rather try and beat the market through good stock selection, then smart beta funds are your best choice; this fund class is known for tracking non-cap weighted strategies.Non-cap weighted indexes try to choose stocks that have a better chance of risk-return performance, which is based on specific fundamental characteristics, or a mix of other such characteristics.The fund has a beta of 0.81 and standard deviation of ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/26ddEdIk.0DefsBmi91u3Q--~B/aD01OTg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/21b1f011539d3e31c28282071d344177"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wisdomtree-international-high-dividend-etf-102005521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739343.SGD","LU2095319765.USD","BK4112","TTE","FDN","LU0320765059.SGD","LU0289960550.SGD","BK4534","MSCI","BK4201","LU0175139822.USD","LU1804176565.USD","LU2129689431.USD","LU0289961442.SGD","LU0511384066.AUD","LU1267930730.SGD","LU2210150020.SGD","LU2210149790.SGD","LU2237443622.USD","BK4504","LU2129689605.HKD","DTH","IEFA","LU2237443978.SGD","LU2265009873.SGD","LU0672654240.SGD","BK4588","BK4585","LU2237443382.USD","LU2237443895.HKD","EFA","BK4581","LU0109391861.USD","LU0708995401.HKD","LU2237443465.HKD","LU2129689514.USD","BK4561","BK4550","LU2237443549.SGD"],"gpt_icon":0},{"id":"2477511950","title":"High Growth Tech Stocks In India For October 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2477511950","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477511950?lang=en_us&edition=fundamental","pubTime":"2024-10-24 09:02","pubTimestamp":1729731768,"startTime":"0","endTime":"0","summary":"The Indian stock market has been navigating a complex landscape influenced by global economic shifts, including the potential impact of the 2024 US presidential election on trade policies, foreign direct investment, and currency strength. In this dynamic environment, high-growth tech stocks in India are particularly attractive to investors seeking opportunities that align with evolving market conditions and strategic international partnerships.Avalon Technologies, amidst a challenging financial landscape with a net loss of INR 23.07 million this quarter compared to last year's net income of INR 70.7 million, still shows promising growth prospects. With revenue expected to surge by 20.4% annually, outpacing the Indian market's growth rate of 10%, and earnings projected to expand by an impressive 42.8% per year, Avalon is navigating through its current volatility towards potentially lucrative horizons. The recent executive shifts, including the appointment of Suresh Veerappan as CFO, sig","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/85V5KcjKsT1tqpAmNqhoUg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1ba5e0e714fefca84db2db816da2999d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/85V5KcjKsT1tqpAmNqhoUg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/1ba5e0e714fefca84db2db816da2999d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-india-010248532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4100","DTH","DTTVY"],"gpt_icon":0},{"id":"2476658140","title":"Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2476658140","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476658140?lang=en_us&edition=fundamental","pubTime":"2024-10-17 20:00","pubTimestamp":1729166400,"startTime":"0","endTime":"0","summary":"Media Release First safety data anticipated before year end with assessment of PK/PD relationships to follow in H1’CY2025 SYDNEY, AUSTRALIA, Oct.  17, 2024  (GLOBE NEWSWIRE) -- Immutep Limited (ASX: I","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/17/2964816/0/en/Immutep-Announces-First-in-Human-Phase-I-Study-of-IMP761-Progresses-to-Dose-Escalation-Portion-of-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTH","IMMP","BK4139"],"gpt_icon":0},{"id":"2475684112","title":"Terms Of Takeover Bid By Tinexta Defence For DTH Set For Oct 14 To Nov 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2475684112","media":"T-Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475684112?lang=en_us&edition=fundamental","pubTime":"2024-10-11 22:38","pubTimestamp":1728657516,"startTime":"0","endTime":"0","summary":"Defence Tech Holding SpA  on behalf of Tinexta Defence Srl:Set With Italy'S Market Watchdog Consob Period Of Takeover Bid For Dth, From Oct 14 To Nov 7. Further Company Coverage: Dth.Mi. (Gdansk Newsroom). ((Gdansk.Newsroom@Thomsonreuters.Com; +48 58 769 66 00;)).","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DTH"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DTH\",params:#limit:5,,,undefined,":[{"date":"2025-03-26","symbol":"DTH","amount":0.215,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-28"},{"date":"2024-12-26","symbol":"DTH","amount":0.4021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-26","defaultRemindTime":1735223400000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-26","currency":"USD","dateTimestamp":1735189200000,"payDate":"2024-12-30"},{"date":"2024-09-25","symbol":"DTH","amount":0.355,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-25","defaultRemindTime":1727271000000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-27","payableDate":"2024-09-25","currency":"USD","dateTimestamp":1727236800000,"payDate":"2024-09-27"},{"date":"2024-06-25","symbol":"DTH","amount":1.015,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"WisdomTree DEFA Equity Income","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-27","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-06-27"},{"date":"2024-03-22","symbol":"DTH","amount":0.27,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-25","defaultRemindTime":1711114200000,"name":"WisdomTree DEFA Equity Income","recordDate":"2024-03-27","payableDate":"2024-03-25","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DTH\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-22","recordDate":"2015-06-24","paymentDate":"2015-06-26","value":0.81866,"currency":"USD"},{"executeDate":"2015-09-21","recordDate":"2015-09-23","paymentDate":"2015-09-25","value":0.32353,"currency":"USD"},{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-28","value":0.27357,"currency":"USD"},{"executeDate":"2016-03-21","recordDate":"2016-03-23","paymentDate":"2016-03-28","value":0.22833,"currency":"USD"},{"executeDate":"2016-06-20","recordDate":"2016-06-22","paymentDate":"2016-06-24","value":0.78,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DTH\",market:\"US\",delay:false,,,undefined,":{}}}